Cube copying test in combination with rCBF or CSF Aβ42 predicts development of Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 25, Issue 6, 2008, Pages 544-552

  Buchhave, Peder ^a,b   Stomrud, Erik ^a,b   Warkentin, Siegbert ^a,b   Blennow, Kaj ^c   Minthon, Lennart ^a,b   Hansson, Oskar ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amyloid; Alzheimer's disease; Cerebrospinal fluid; Clock drawing test; Cube copying test; Longitudinal study; Mild cognitive impairment; Regional cerebral blood flow

Indexed keywords

AMYLOID BETA PROTEIN[1-42];

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; DRAWING; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK ASSESSMENT; ROC CURVE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AREA UNDER CURVE; BRAIN; COGNITION DISORDERS; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; XENON RADIOISOTOPES;

EID: 46849083714     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000137379     Document Type: Article

References (39)

1. Blennow K, de Leon MJ, Zetterberg H: Alzheimer's disease. Lancet 2006;368:387-403.
2. Price JL, Morris JC: Tangles and plaques in nondemented aging and 'preclinical' Alzheimer's disease. Ann Neurol 1999;45:358-368.
3. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
4. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B: Mild cognitive impairment. Lancet 2006;367:1262-1270.
5. Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG: Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 2006;67:2176-2185.
6. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
7. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). V. A normative study of the neuropsychological battery. Neurology 1994;44:609-614.
8. Maeshima S, Itakura T, Nakagawa M, Nakai K, Komai N: Visuospatial impairment and activities of daily living in patients with Parkinson's disease: a quantitative assessment of the cube-copying task. Am J Phys Med Rehabil 1997;76:383-388.
9. Maeshima S, Osawa A, Maeshima E, Shimamoto Y, Sekiguchi E, Kakishita K, Ozaki F, Moriwaki H: Usefulness of a cube-copying test in outpatients with dementia. Brain Inj 2004;18:889-898.
10. Shulman KI: Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000;15:548-561.
11. Griffith HR, Netson KL, Harrell LE, Zamrini EY, Brockington JC, Marson DC: Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period. J Int Neuropsychol Soc 2006;12:166-175.
12. Huang C, Wahlund LO, Almkvist O, Elehu D, Svensson L, Jonsson T, Winblad B, Julin P: Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage 2003;19:1137-1144.
13. Huang C, Eidelberg D, Habeck C, Moeller J, Svensson L, Tarabula T, Julin P: Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT. Neurobiol Aging 2007;28:1062-1069.
14. Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, Terzi A, Vignolo LA, Di Luca M, Giubbini R, Padovani A, Perani D: Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 2006;27:24-31.
15. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
16. Association AP: Diagnostic and Statistical Manual of Mental Disorders, ed 3, rev. Arlington, USA, American Psychiatric Association, 1987.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
18. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al: Vascular dementia: diagnostic criteria for research studies - Report of the NINDS-AIREN international workshop. Neurology 1993;43:250-260.
19. McKeith IG, Perry EK, Perry RH, Consortium on Dementia with Lewy Bodies: Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Neurology 1999;53:902-905.
20. Brun A, Englund E, Gustafson L, Passant U, Mann D, Neary D, Snowden J, the Lund and Manchester groups: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
21. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
22. Manos PJ, Wu R: The ten-point clock test: a quick screen and grading method for cognitive impairment in medical and surgical patients. Int J Psychiatry Med 1994;24:229-244.
23. Shulman KI, Gold DP, Cohen CA, Zucchero CA: Clock-drawing and dementia in the community: a longitudinal study. Int J Geriatr Psychiatry 1993;8:487-496.
24. Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, Grafman JH: Clock drawing in Alzheimer's disease: a novel measure of dementia severity. J Am Geriatr Soc 1989;37:725-729.
25. Shulman KI, Shedletsky R, Silver IL: The challenge of time: clock-drawing and cognitive function in the elderly. Int J Geriatr Psychiatry 1986;1:135-140.
26. Obrist WD, Thompson HK Jr, Wang HS, Wilkinson WE: Regional cerebral blood flow estimated by 133-xenon inhalation. Stroke 1975;6:245-256.
27. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006;5:228-234.
28. Perkins NJ, Schisterman EF: The inconsistency of 'optimal' cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006;163:670-675.
29. Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S: Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging, in press.
30. Blennow K, Hampel H: CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003;2:605-613.
31. Backman L, Jones S, Berger AK, Laukka EJ, Small BJ: Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 2005;19:520-531.
32. Ericsson K, Forssell LG, Holmen K, Viitanen M, Winblad B: Copying and handwriting ability in the screening of cognitive dysfunction in old age. Arch Gerontol Geriatr 1996;22:103-121.
33. Schott JM, Kennedy J, Fox NC: New developments in mild cognitive impairment and Alzheimer's disease. Curr Opin Neurol 2006;19:552-558.
34. Skoog I, Davidsson P, Aevarsson O, Vanderstichele H, Vanmechelen E, Blennow K: Cerebrospinal fluid β-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds. Dement Geriatr Cogn Disord 2003;15:169-176.
35. Stomrud E, Hansson O, Blennow K, Minthon L, Londos E: Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly. Dement Geriatr Cogn Disord 2007;24:118-124.
36. 42 ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 2007;64:343-349.
37. 1-42 in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 1999;56:673-680.
38. Blennow K, Zetterberg H, Minthon L, Lannfelt L, Strid S, Annas P, Basun H, Andreasen N: Longitudinal stability of CSF biomarkers in Alzheimer's disease. Neurosci Lett 2007;419:18-22.
39. Bruscoli M, Lovestone S: Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr 2004;16:129-140.